Home › Funds › Opaleye Management Inc. › STOK
Opaleye Management Inc. position in STOK
STOKE THERAPEUTICS INC · Health Care
Opaleye Management Inc. reported holding 700,000 shares of STOK (STOKE THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$22.9M, representing 2.07% of its reported portfolio and ranking #13 among its reported holdings. Opaleye Management Inc. has disclosed STOK holdings in 7 of the last 7 reported quarters, going back to Q4 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Opaleye Management Inc.'s STOK position evolved
Opaleye Management Inc. first disclosed a stake in STOK in Q4 2024 at 25,000 shares (US$276K). The position peaked in Q2 2026 at 700,000 shares, worth US$22.9M. Across 7 filings, Opaleye Management Inc. increased the stake 5 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 700,000 shares valued at US$22.9M. Notable position changes include a 1100% increase in Q1 2025 (shares rose 71% over the following quarter), a 87% increase in Q2 2025 (shares rose 107% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 25.00K | $275.75K | New |
| Q1 2025 | 300.00K | $2.00M | Add |
| Q2 2025 | 562.12K | $6.38M | Add |
| Q3 2025 | 682.02K | $16.03M | Add |
| Q4 2025 | 695.00K | $22.06M | Add |
| Q1 2026 | 700.00K | $22.79M | Add |
| Q2 2026 | 700.00K | $22.90M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About STOK and 13F data
STOK (STOKE THERAPEUTICS INC) is a Health Care company. 52 other funds we track also report a position in STOK — the largest reported positions include RTW INVESTMENTS, LP (US$184.0M), Lynx1 Capital Management LP (US$132.1M), Redmile Group, LLC (US$129.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding STOK
- RTW INVESTMENTS, LP 5.62M sh · $184.00M · Q2 2026
- Lynx1 Capital Management LP 4.04M sh · $132.14M · Q2 2026
- Redmile Group, LLC 3.95M sh · $129.11M · Q2 2026
- BAKER BROS. ADVISORS LP 3.34M sh · $109.18M · Q2 2026
- TORONTO DOMINION BANK 3.17M sh · $103.83M · Q2 2026
- BVF INC/IL 2.55M sh · $83.36M · Q2 2026
- Siren, L.L.C. 2.00M sh · $65.29M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 1.82M sh · $59.66M · Q2 2026
- EcoR1 Capital, LLC 735.00K sh · $24.05M · Q2 2026
- MPM BioImpact LLC 723.31K sh · $23.67M · Q2 2026
- Troluce Capital Advisors LLC 496.42K sh · $16.24M · Q2 2026
- Granahan Investment Management, LLC 461.61K sh · $15.10M · Q2 2026
More on Opaleye Management Inc.
FAQ
How long has Opaleye Management Inc. held STOK?
Opaleye Management Inc. has disclosed STOK holdings in 7 of the last 7 reported quarters, going back to Q4 2024.
What is Opaleye Management Inc.'s current position in STOK?
As of Q2 2026, Opaleye Management Inc. holds 700.00K shares of STOK (STOKE THERAPEUTICS INC), valued at $22.90M, representing 2.07% of its reported portfolio and ranking #13.
Has Opaleye Management Inc. been buying or selling STOK?
In the latest 13F filing (Q2 2026), Opaleye Management Inc. held unchanged its position in STOK. The position peaked in Q2 2026 at 700.00K shares.
Which other funds hold STOK?
Other major institutional holders of STOK include RTW INVESTMENTS, LP, Lynx1 Capital Management LP, Redmile Group, LLC, among 52 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.